Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

BiTE antibody AMG 910

A half-life extended (HLE), bispecific T-cell engager (BiTE) antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 910 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:bispecific antibody AMG 910
bispecific T-cell engager AMG 910
bispecific T-cell engager antibody AMG 910
Code name:AMG 910
AMG-910
AMG910
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search